Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Blood
|
August 28, 2007
Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells
Joanne R Flavell, Karl R N Baumforth, Victoria H J Wood, et al.
BJU International
|
September 26, 2024
Real-world outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial
Samantha Conroy, Ibrahim Jubber, Aidan P Noon, et al.
Oncotarget
|
January 18, 2015
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis
Marco Scarpa, Paola Brun, Melania Scarpa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 11, 2019
Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells
Chiara Marchiori, Melania Scarpa, Andromachi Kotsafti, et al.
Oncogenesis
|
August 2, 2018
Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
Imerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Oncogenesis
|
June 20, 2018
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
Imerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Internal Medicine Journal
|
July 8, 2024
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era
Diva Baggio, Eliza Chung, Cameron Wellard, et al.
Blood
|
June 4, 2005
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells
Karl R N Baumforth, Joanne R Flavell, Gary M Reynolds, et al.
Investigational New Drugs
|
April 25, 2022
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
Patricia LoRusso, Mark J Ratain, Toshihiko Doi, et al.
The Journal of Pathology
|
January 15, 2009
The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma
Shikha Bose, Lee-Fah Yap, Matthew Fung, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Blood
|
August 28, 2007
Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells
Joanne R Flavell, Karl R N Baumforth, Victoria H J Wood, et al.
BJU International
|
September 26, 2024
Real-world outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial
Samantha Conroy, Ibrahim Jubber, Aidan P Noon, et al.
Oncotarget
|
January 18, 2015
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis
Marco Scarpa, Paola Brun, Melania Scarpa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 11, 2019
Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells
Chiara Marchiori, Melania Scarpa, Andromachi Kotsafti, et al.
Oncogenesis
|
August 2, 2018
Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
Imerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Oncogenesis
|
June 20, 2018
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
Imerio Angriman, Lucrezia Furian, Melania Scarpa, et al.
Internal Medicine Journal
|
July 8, 2024
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era
Diva Baggio, Eliza Chung, Cameron Wellard, et al.
Blood
|
June 4, 2005
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells
Karl R N Baumforth, Joanne R Flavell, Gary M Reynolds, et al.
Investigational New Drugs
|
April 25, 2022
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
Patricia LoRusso, Mark J Ratain, Toshihiko Doi, et al.
The Journal of Pathology
|
January 15, 2009
The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma
Shikha Bose, Lee-Fah Yap, Matthew Fung, et al.
Page
of 7